337 related articles for article (PubMed ID: 12952927)
21. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor.
Wilkins GE; Granleese S; Hegele RG; Holden J; Anderson DW; Bondy GP
J Clin Endocrinol Metab; 1995 May; 80(5):1628-34. PubMed ID: 7745010
[TBL] [Abstract][Full Text] [Related]
22. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity.
Miyauchi A; Fukase M; Tsutsumi M; Fujita T
J Clin Endocrinol Metab; 1988 Jul; 67(1):46-53. PubMed ID: 2837500
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of renal phosphate loss in liver resection-associated hypophosphatemia.
Nafidi O; Lapointe RW; Lepage R; Kumar R; D'Amour P
Ann Surg; 2009 May; 249(5):824-7. PubMed ID: 19387319
[TBL] [Abstract][Full Text] [Related]
24. Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia.
Green J; Debby H; Lederer E; Levi M; Zajicek HK; Bick T
Kidney Int; 2001 Sep; 60(3):1182-96. PubMed ID: 11532115
[TBL] [Abstract][Full Text] [Related]
25. Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats.
Takemoto F; Shinki T; Yokoyama K; Inokami T; Hara S; Yamada A; Kurokawa K; Uchida S
Kidney Int; 2003 Aug; 64(2):414-20. PubMed ID: 12846736
[TBL] [Abstract][Full Text] [Related]
26. New insights into phosphate homeostasis: fibroblast growth factor 23 and frizzled-related protein-4 are phosphaturic factors derived from tumors associated with osteomalacia.
Kumar R
Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):547-53. PubMed ID: 12187320
[TBL] [Abstract][Full Text] [Related]
27. Tumor-induced osteomalacia and the regulation of phosphate homeostasis.
Kumar R
Bone; 2000 Sep; 27(3):333-8. PubMed ID: 10962341
[TBL] [Abstract][Full Text] [Related]
28. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase.
Tenenhouse HS; Jones G
Endocrinology; 1987 Feb; 120(2):609-16. PubMed ID: 3803293
[TBL] [Abstract][Full Text] [Related]
29. The phosphatonin pathway: new insights in phosphate homeostasis.
Schiavi SC; Kumar R
Kidney Int; 2004 Jan; 65(1):1-14. PubMed ID: 14675031
[TBL] [Abstract][Full Text] [Related]
30. Tumor-induced osteomalacia: clinical and basic studies.
Shane E; Parisien M; Henderson JE; Dempster DW; Feldman F; Hardy MA; Tohme JF; Karaplis AC; Clemens TL
J Bone Miner Res; 1997 Sep; 12(9):1502-11. PubMed ID: 9286768
[TBL] [Abstract][Full Text] [Related]
31. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium.
Bland R; Walker EA; Hughes SV; Stewart PM; Hewison M
Endocrinology; 1999 May; 140(5):2027-34. PubMed ID: 10218951
[TBL] [Abstract][Full Text] [Related]
32. Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels.
Anderson PH; O'Loughlin PD; May BK; Morris HA
Bone; 2005 Apr; 36(4):654-62. PubMed ID: 15781002
[TBL] [Abstract][Full Text] [Related]
33. Effect of parathyroid hormone on cAMP and 1,25-dihydroxyvitamin D formation and renal handling of phosphate in vitamin D-dependent rickets.
Aarskog D; Aksnes L; Markestad T
Pediatrics; 1983 Jan; 71(1):59-63. PubMed ID: 6294581
[TBL] [Abstract][Full Text] [Related]
34. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus.
St-Arnaud R; Messerlian S; Moir JM; Omdahl JL; Glorieux FH
J Bone Miner Res; 1997 Oct; 12(10):1552-9. PubMed ID: 9333115
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms whereby extracellular adenosine 3',5'-monophosphate inhibits phosphate transport in cultured opossum kidney cells and in rat kidney. Physiological implication.
Friedlander G; Couette S; Coureau C; Amiel C
J Clin Invest; 1992 Sep; 90(3):848-58. PubMed ID: 1325999
[TBL] [Abstract][Full Text] [Related]
36. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
[TBL] [Abstract][Full Text] [Related]
37. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of renal type IIa sodium-dependent phosphate cotransporter during lipopolysaccharide-induced acute inflammation.
Ikeda S; Yamamoto H; Masuda M; Takei Y; Nakahashi O; Kozai M; Tanaka S; Nakao M; Taketani Y; Segawa H; Iwano M; Miyamoto K; Takeda E
Am J Physiol Renal Physiol; 2014 Apr; 306(7):F744-50. PubMed ID: 24500689
[TBL] [Abstract][Full Text] [Related]
39. Variable phosphate-mediated regulation of vitamin D metabolism in the murine hypophosphatemic rachitic/osteomalacic disorders.
Davidai GA; Nesbitt T; Drezner MK
Endocrinology; 1991 Mar; 128(3):1270-6. PubMed ID: 1999147
[TBL] [Abstract][Full Text] [Related]
40. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
